Financing for growth companies within life science
What we offer
Sciety provides the entire project management of the process from production of presentation material to the funds arriving in your account. We initiate cooperation by identifying your requirements and establishing a time plan. Based on our specialist competence in life science and a structured approach, we contribute with an in-depth understanding of your operations, as well as expertise in the most efficient means of achieving your goals. Sciety assists in producing investment material, communication with investors and the administration of the investments.
Is this for you
Sciety focuses on prominent companies within biotechnology, digital health, pharmacology, ICT in healthcare and medical technology seeking to raise MSEK 10-100. The companies’ development phase depends on the area and innovation level. Pharmaceutical companies should be in the late preclinical phase or early clinical phase, while companies within digital health should have an initial user base. Sciety has a structured process for selecting and reviewing companies in which business potential and medical and legal aspects are analysed.
This is what our clients think
"I am very happy with the collaboration and the successful outcome of the financing with Sciety. Even in the current situation with Covid-19, that significantly affects the investment climate, Sciety succeeded to raise the capital at a short period of time. We are happy about the interest for our unique treatment candidate and welcome our new shareholders."
Fredrik Lehman, chairman of the board and co-founder, Synartro
"Sciety gave excellent support throughout the financing process. In addition to the professional contacts with relevant investors, I appreciated the flexibility and drive in the process. The outcome was very successful with a fully financed business plan and a strong group of new shareholders that shares our vision."
Karl Bergman, CEO at Elypta
“As founder and Managing Director, I am very satisfied with Sciety’s services. With a friendly approach and exceptional business development skills, Sciety educated and trained us to reach our goals. Sciety provided investments and invaluable expertise for EMPE Diagnostics AB which develops quick diagnostics for antibiotic resistance with a special focus on tuberculosis. I can strongly recommend Sciety.”
Pavan Asalapuram, CEO at EMPE Diagnostics
“Sciety offers a professional and structured means of accessing financing at an early stage. Life science projects are often difficult to analyse and, therefore, Sciety’s focus on this segment is positive for both companies seeking financing and for investors seeking new investment possibilities.”
Fredrik Sjövall, CEO at Inhalation Sciences
"Sciety contributed with valuable competence and a structured process. They assumed responsibility for all necessary agreements and the planning and project management needed for the financing. The investments from their network gave Predicare access to capital that enables our broader expansion in Europe and further development of our product portfolio."
Mathias Myrén, CEO at Predicare
"The Sciety team is professional with a rare blend of expertise in life science, finance and entrepreneurship. Their network of investors is of great value for high tech companies such as Attana. Thanks to our fundraising with Sciety, we have also gained new, valuable competence in our board."
Teodor Aastrup, CEO at Attana
Communication with the capital markets
What we offer
Sciety works proactively in communicating about the company to potential investors and to strengthen their relationships with existing shareholders. Based on our experience within life science and digital communication, we transform complex information to effective communication. Included in our communication package are, amongst other things, the design and distribution of press releases, communication in social media and digital channels, build up of the home web page and implementation of analysis tools.
Is this for you
In the growth phase the core operations often receive all of the focus and it can be difficult to find time for communication. At the same time, relevant and continual communication is something which investors value notably. Our communications package is aimed at companies wishing to build up long-term relationships in the capital market in order to facilitate future capital acquisition. These services are appropriate for small and medium-sized companies within life science where there is a need of external capital within a three-year period.
What our clients think
“Sciety took care of all communication in conjunction with securing capital for our company. Their understanding of life science and finance made it possible for us to produce relevant and clear content in press releases and similar communication.
Through Sciety’s channels, we received market exposure in, amongst other places, Dagens Industri’s web page, something that was very valuable”.
Carina Schmidt, CEO at Athera Biotechnologies